Free Republic

Is Obama Planning to Flood the System With Foreign Ebola Patients? As if the last few weeks have not been crazy enough. First we learned that a Liberian national who landed in Dallas had tested positive for Ebola. We then witnessed a comedy of errors as workers and authorities tried to deal with "patient zero." Shortly after we learned that not just one, but two nurses who treated Thomas Duncan had also been stricken with Ebola. Now we are hearing from Judicial Watch that Barack Obama is planning to bring more Ebola patients to America… on purpose. Maybe that is...

Judicial Watch has learned that the Obama administration is actively formulating plans to admit Ebola-infected non-U.S. citizens into the United States for treatment. Specifically, the goal of the administration is to bring Ebola patients into the United States for treatment within the first days of diagnosis. It is unclear who would bear the high costs of transporting and treating non-citizen Ebola patients. The plans include special waivers of laws and regulations that ban the admission of non-citizens with a communicable disease as dangerous as Ebola. One source tells us that the Obama administration is keeping this plan secret from Congress....

There are four places in the United States set up to handle a patient sickened by the Ebola virus, and Missoula is one of those. .... And any hospital equipped to care for a tuberculosis patient can care for an Ebola patient, according to Dr. George Risi, an infectious disease specialist who recently returned from spending 20 days in a Sierra Leone Ebola ward. Accompanied by St. Patrick’s intensive care nursing director Kate Hurley, Risi helped local clinic staff care for up to 95 patients at a time. While untreated Ebola kills more than 70 percent of its victims, more...

Three top secret, experimental vials stored at subzero temperatures were flown into Liberia last week in a last-ditch effort to save two American missionary workers who had contracted Ebola, according to a source familiar with details of the treatment. A representative from the National Institutes of Health contacted Samaritan's Purse in Liberia and offered the experimental treatment, known as ZMapp, for the two patients, according to the source. The drug was developed by the biotech firm Mapp Biopharmaceutical Inc. The patients were told that this treatment had never been tried before in a human being but had shown promise in...